Successful Partnerships Begin with a Conversation--Meet Us in Boston
At PBL Assay Science, we're heading into AAPS National Biotechnology Conference (NBC) 2025 with focused intent and renewed momentum. In past years, this meeting has sparked successful collaborations from thoughtful discussions, and we’re excited to return to this uniquely intimate and high-impact event in Boston, MA.
Why NBC is the Right Place to Meet with the PBL Team
NBC isn’t just another industry meeting—it’s a focused gathering of 200–300 translational scientists, clinical development leads, and biomarker experts. Its scale creates space for personalized discussions that can lead to actionable partnerships. “This isn’t a pitch fest,” says Alok Pandey, PhD, Vice President, Biomarker and Translational Science at PBL. “It’s where we connect directly with scientists working on complex therapeutic programs—people looking for a thought partner, not just another vendor.”
Products and Services That Power Translational Research
This year, our presence expands with a dedicated booth and a renewed focus on what we do best: providing customized, scientifically sound biomarker support, including:
- Advanced ultra- and high-sensitivity immunoassay services using platforms like SMCxPRO, SIMOA, MSD (V-Plex, S-Plex, U-Plex), and Luminex
- Tailored custom immunoassay development for pharmacodynamic (PD) biomarkers
- Expert biomarker strategy consulting across the continuum, from preclinical PD biomarker planning to exploratory endpoint support and analysis in Phase 1 to Phase 3 clinical trials
- New assay high-sensitivity ELISA kits for IL-15 and IL-22, along with our market-leading interferon kits, widely trusted for quality and specificity
Our guiding principle is strategic clarity, empowering drug development teams to make informed decisions backed by fit-for-purpose bioanalytical data. Our theme this year? Actionable Expertise. We go beyond the bench to help define and refine biomarker strategies that move your program forward.
Who We Are Looking Forward to Seeing in Boston...
We welcome connections with teams working across:
- Virtual and small biotechs who need full biomarker support without full infrastructure
- Mid-sized and large pharma teams with biomarker goals but limited internal bandwidth
- Clinical-stage programs in need of agile, science-first collaborations that can evolve alongside the study. We're not here to pitch. We're here to partner--whether that means freeing up your sample backlog, helping design your biomarker strategy, or simply listening to your program's challenges
Let's Talk There--By Scheduling Now!
With a limited number of days and only a few team members attending, our meeting schedule is filling up fast. If you’d like to secure time with our scientific team—including a direct conversation with Alok—click the link below and lock in a time before the show begins.
Schedule a meeting with PBL's Scientific Team
We’ll be at Booth 404—but your best conversations start before you get there. Don’t wait.
We’re ready to bring clarity, strategy, and real solutions to your biomarker challenges. Let’s make NBC 2025 count.